May 2018

George Chen

Professor George Guo-Qiang CHEN received his BSc and PhD from South China University of Technology in 1985 and Graz University of Technology (Austria) in 1989, respectively. He also conducted research in 1990-1994 as a postdoc at University of Nottingham in UK and University of Alberta in Canada, respectively. He has been focusing his research on microbial materials polyhydroxyalkanoates (PHA) metabolic engineering and PHA biomaterials application since 1986. After joining Tsinghua University in 1994, he has been actively promoting the microbial Bio- and Material Industries in China....Read more

Read more about George Chen

Jamie Cate

Dr. Cate has had a longstanding interest in understanding how the ribosome translates the genetic code into proteins. A major focus in his lab is the study of human translation, focusing on the role of human translation initiation factor eIF3 and on ribosome stalling mechanisms. Using biochemical and structural biology, his lab has revealed fundamental mechanisms of human translation initiation, including the discovery of a 5’-m7G mRNA cap-binding activity in human eIF3 and eIF3-mediated regulation of specific mRNAs. In collaboration with Pfizer, his lab also revealed a new molecular...Read more

Read more about Jamie Cate

Lars Blank

Lars M. Blank studied Chemical Engineering from 1990 to 1997 at the University of Dortmund (Germany) and Biology from 1992 to 1997 at the Ruhr-University of Bochum (Germany). During his master theses he worked in the field of Metabolic Engineering in the group of Prof. E. T. Papoutsakis at Northwestern University, IL, USA and in yeast cell biology in the group of Prof. W.-H. Kunau at the Ruhr-University of Bochum. In his Ph.D. in the group of Prof. L. K. Nielsen at the University of Queensland, Australia (1998 to 2002), he developed a continuous process for hyaluronic acid production using...Read more

Read more about Lars Blank

Matthew Chang

Matthew Chang is Director of the Singapore Consortium for Synthetic Biology (SINERGY), Wilmar-NUS Corporate Laboratory (WIL@NUS), and NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI) and Dean’s Chair in Medicine and Associate Professor of Biochemistry and Synthetic Biology in the Yong Loo Lin School of Medicine at the National University of Singapore.

His research focuses on studying the engineering of biology to develop autonomous, programmable cells, supported by local and international organizations and industry. In particular, he has significantly...Read more

Read more about Matthew Chang

2019 Synthetic Biology: Engineering, Evolution & Design (SEED)

June 23, 2019 to June 27, 2019

New York Hilton – Midtown

SEED 2019 will focus on advances in science, technology, applications, and related investments in the field of synthetic biology.

Read more about 2019 Synthetic Biology: Engineering, Evolution & Design (SEED)

Although deep learning, a branch of artificial intelligence, has become prominent only recently, it is based on concepts that are familiar to chemical engineers. This article describes artificial neural networks — the algorithms that enable deep learning.

June

2018

RAPID Technology Speed Dating Event Leads to Matches!

May 29, 2018

Several members at RAPID’s Technology Speed Dating event made numerous connections and business matches last month. In all, 27 members disseminated information on their process intensification (PI) technologies—from nascent concepts and technologies to more mature ones with possibilities for...

Announcement